Zura Bio Limited (ZURA)

Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022
Cash & Equivalents	188.22	99.81	1.57	4.72
Cash & Short-Term Investments	188.22	99.81	1.57	4.72
Cash Growth	81.23%	6269.24%	-66.80%	-
Prepaid Expenses	0.75	1.04	0.21	-
Total Current Assets	188.98	100.84	1.78	4.72
Long-Term Deferred Charges	-	-	3.49	-
Total Assets	189.07	100.84	5.26	4.72
Accounts Payable	1.6	2.75	2.01	0.01
Accrued Expenses	1.94	1.31	0.82	-
Short-Term Debt	-	-	7.76	-
Other Current Liabilities	14.71	16.24	4.23	0.03
Total Current Liabilities	18.24	20.3	14.82	0.04
Other Long-Term Liabilities	-	0.99	-	-
Total Liabilities	18.24	21.29	14.82	0.04
Common Stock	0.01	0	-	-
Additional Paid-In Capital	295.31	162.82	-	-
Retained Earnings	-142.27	-103.49	-32.06	-7.82
Total Common Equity	153.05	59.33	-32.06	-7.82
Minority Interest	17.78	20.22	10	-
Shareholders' Equity	170.83	79.55	-9.56	4.68
Total Liabilities & Equity	189.07	100.84	5.26	4.72
Total Debt	-	-	7.76	-
Net Cash (Debt)	188.22	99.81	-6.19	4.72
Net Cash Per Share	2.94	3.02	-27.13	-
Filing Date Shares Outstanding	65.29	43.59	43.09	17.25
Total Common Shares Outstanding	65.29	43.59	0.38	17.25
Working Capital	170.73	80.54	-13.04	4.68
Book Value Per Share	2.34	1.36	-83.59	-0.45
Tangible Book Value	153.05	59.33	-32.06	-7.82
Tangible Book Value Per Share	2.34	1.36	-83.59	-0.45

Source: S&P Capital IQ. Standard template. Financial Sources.